Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Karlan

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2020
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among <i>BRCA1</i> and <i>BRCA2</i> mutation carriersJoanne Kotsopoulos, Beth Karlan, Jacek Gronwald, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 15, 2014
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutationsYaser R Hussein, Britta Weigelt, Douglas A Levine, et al.
Gynecologic Oncology|March 19, 2017
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?Jacob McGee, Vasily Giannakeas, Beth Karlan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriersJoanne Kotsopoulos, Parviz Ghadirian, Ahmed El-Sohemy, et al.
Fertility and Sterility|February 19, 2013
Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutationAmy Finch, Adriana Valentini, Ellen Greenblatt, et al.
Clinical Genetics|December 13, 2021
The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delTAmy Finch, Kelly Metcalfe, Mohammad Akbari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2005
Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancerDavid B Agus, Michael S Gordon, Charles Taylor, et al.
International Journal of Cancer|January 14, 2018
The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriersKwang-Pil Ko, Shana J Kim, Tomasz Huzarski, et al.
Menopause (New York, N.Y.)|October 24, 2019
Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?Joanne Kotsopoulos, Jacek Gronwald, Jan Lubinski, et al.
Breast Cancer Research and Treatment|October 16, 2015
Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?John Semple, Kelly A Metcalfe, Jan Lubinski, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2020
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among <i>BRCA1</i> and <i>BRCA2</i> mutation carriersJoanne Kotsopoulos, Beth Karlan, Jacek Gronwald, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 15, 2014
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutationsYaser R Hussein, Britta Weigelt, Douglas A Levine, et al.
Gynecologic Oncology|March 19, 2017
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?Jacob McGee, Vasily Giannakeas, Beth Karlan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriersJoanne Kotsopoulos, Parviz Ghadirian, Ahmed El-Sohemy, et al.
Fertility and Sterility|February 19, 2013
Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutationAmy Finch, Adriana Valentini, Ellen Greenblatt, et al.
Clinical Genetics|December 13, 2021
The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delTAmy Finch, Kelly Metcalfe, Mohammad Akbari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2005
Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancerDavid B Agus, Michael S Gordon, Charles Taylor, et al.
International Journal of Cancer|January 14, 2018
The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriersKwang-Pil Ko, Shana J Kim, Tomasz Huzarski, et al.
Menopause (New York, N.Y.)|October 24, 2019
Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?Joanne Kotsopoulos, Jacek Gronwald, Jan Lubinski, et al.
Breast Cancer Research and Treatment|October 16, 2015
Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?John Semple, Kelly A Metcalfe, Jan Lubinski, et al.
Pageof 9